PET scan can non invasively measure early assessment of treatment for common type of breast cancer

Non-invasive imaging can measure how well patients with the most common form of breast cancer - estrogen receptor positive type - respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to a poster presentation to be presented at the ASCO annual meeting next week.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news162567550.html">PET scan can non invasively measure early assessment of treatment for common type of breast cancer</a></p> <p>Non-invasive imaging can measure how well patients with the most common form of breast cancer - estrogen receptor positive type - respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to a poster presentation to be presented at the ASCO annual meeting next week.</p>